Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Among HIV-infected Adults
Conditions: Streptococcal Pneumonia; HIV/AIDS Intervention: Biological: Prevenar13 Sponsor: Korea University Guro Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2019 Category: Research Source Type: clinical trials